SOLV Energy, Inc.

(Incorporated in Delaware) We are a leading provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. We have constructed more than 500 power plants representing 20 GWdc of generating capacity since we were founded in 2008, and we currently provide O&M (operations and maintenance) services under […]

January 17, 2026 Read More

SpyGlass Pharma, Inc.

(Incorporated in Delaware) We are a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions – specifically, open-angle glaucoma (OAG) or ocular hypertension (OHT) – through long-acting sustained drug delivery of approved medicines. Our mission is to significantly improve the lives of these patients by developing durable drug […]

January 16, 2026 Read More

AgomAb Therapeutics

(Incorporated in Belgium) We are a Phase 2 clinical biotech focused on discovering and/or developing new treatments for diseases in the immunology and inflammatory category. Our leading product candidates are: *Ontunisertib (AGMB-129) – An oral treatment for Crohn’s disease with fibrostenosis, and *AGMB-447 –  An inhaled treatment for idiopathic pulmonary fibrosis (IPF). Our product candidates […]

Read More

Rank One Computing Corp.

(Incorporated in Colorado) Founded in 2015, ROC is a consistently top-tier rated U.S.-built, U.S.-owned, and U.S.-operated provider of advanced biometric, facial recognition, and Vision AI solutions. We develop and deploy innovative technologies that enhance safety, security, and convenience globally, while upholding principles of fairness and privacy. Our solutions are trusted by U.S. and international military […]

January 14, 2026 Read More

AGI

(Incorporated in the Cayman Islands) Our journey began over 25 years ago with a vision from our founder, Mr. Marciano Testa: to make credit more accessible and affordable for the Brazilian consumers who needed it most. While still a college student in 1999, Mr. Testa founded Agiplan, the first building block of what eventually became […]

Read More

Liftoff Mobile

(Incorporated in Delaware) Liftoff is a mission-critical growth monetization engine for the app economy. Our AI-powered platform is designed to serve all verticals in the app ecosystem and is fully integrated to drive differentiated advertising performance for our customers across the app economy. We deliver profitable users for app advertisers and help to maximize advertising […]

Read More

Veradermics, Inc.

(Incorporated in Delaware) We are a clinical biotech working to develop an oral treatment – called VDPHL01 – for pattern hair loss (PHL) in men and women in Phase II and Phase III clinical trials. VDPHL01 is an oral extended-release (ER) formulation of minoxidil, which was originally designed to treat resistant hypertension. We are currently […]

Read More

KRAKacquisition Corp.

(Incorporated in the Cayman Islands) We are a newly established blank check company, also known as a SPAC. We intend to focus our search for an acquisition target on companies involved in the digital economy and its infrastructure, particularly companies whose focus is on the intersection of DeFi (decentralized finance, including the blockchain economy) and […]

January 12, 2026 Read More

EUPEC International Group Ltd.

(Incorporated in the Cayman Islands) We provide comprehensive, high-performance coating solutions for onshore and offshore steel pipelines in the water, oil and gas sectors. Our specialized services include linepipe coating, custom coating, field joint coating and reel-to-reel coating, supporting pipeline installation contractors and asset owners worldwide. We serve past and present leading industry players such as Total […]

Read More

Eikon Therapeutics

(Incorporated in Delaware) We are a clinical pharmaceutical company focused on developing drugs to treat several types of cancer. We are conducting clinical trials for several drug candidates in our pipeline: EIK1001 to treat advanced melanoma – Phase 2/3 trials with our 740 patients in 22 countries; EIK1001 to treat Stage 4 non-small cell lung […]

January 9, 2026 Read More